← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
351	UBS O'Connor Chicago, Illinois	$37.5M	+$38.6M	6	0.7%	New
352	WBC Westpac Banking Corp Sydney, Australia	$37.4M	+$39.7M	6	0.57%	New
353	Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada	$36.6M	+$36.4M	6	0.29%	New
354	JP Morgan Private Wealth Advisors San Francisco, California	$36.5M	+$37M	3	0.9%	New
355	SAM Shell Asset Management The Hague, Netherlands	$36.4M	+$35.9M	7	0.69%	New
356	BCM Brown Capital Management Baltimore, Maryland	$35.8M	+$38.3M	3	0.77%	New
357	BC Broadwood Capital New York	$35.7M	+$35.8M	1	8.12%	New
358	Bartlett & Co Cincinnati, Ohio	$35.6M	+$36.6M	5	1.96%	New
359	VVP Vulcan Value Partners Birmingham, Alabama	$35.5M	+$35.8M	1	1.56%	New
360	Mondrian Investment Partners London, United Kingdom	$35.5M	+$36.4M	1	0.54%	New
361	KBC Group Brussels, Belgium	$35M	+$35.1M	8	0.65%	New
362	TSU TD Securities (USA) New York	$35M	+$34.8M	5	0.7%	New
363	Deerfield Management New York	$35M	+$31.7M	4	1.65%	New
364	RIG Roosevelt Investment Group New York	$34.8M	+$36M	3	1.56%	New
365	RS Investment Management San Francisco, California	$34.8M	+$35.9M	2	0.25%	New
366	Fjarde Ap-fonden Stockholm, Sweden	$34.6M	+$33.9M	5	0.72%	New
367	Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania	$34.4M	+$32.7M	8	0.59%	New
368	NG NatWest Group Edinburgh, Scotland, United Kingdom	$34.3M	+$33.9M	9	0.49%	New
369	Castleark Management Chicago, Illinois	$33.8M	+$34.1M	2	1.12%	New
370	PRA Parametric Risk Advisors Westport, Connecticut	$33.6M	+$34.2M	2	2.32%	New
371	Gabelli Funds Rye, New York	$33.4M	+$33.7M	4	0.2%	New
372	CC Carlson Capital Dallas, Texas	$32.9M	+$33.1M	1	0.39%	New
373	PP PDT Partners New York	$32.8M	+$32.8M	11	0.8%	New
374	Slate Path Capital New York	$32.5M	+$27.9M	1	1.76%	New
375	OPCM Osborne Partners Capital Management San Francisco, California	$32.5M	+$32.2M	4	4.66%	New